127 related articles for article (PubMed ID: 12174874)
1. EMMPRIN (CD 147) is expressed in Hodgkin's lymphoma and anaplastic large cell lymphoma. An immunohistochemical study of 60 cases.
Thorns C; Feller AC; Merz H
Anticancer Res; 2002; 22(4):1983-6. PubMed ID: 12174874
[TBL] [Abstract][Full Text] [Related]
2. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
[TBL] [Abstract][Full Text] [Related]
3. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
5. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
6. Matrix-metalloproteinases in Hodgkin lymphoma.
Thorns C; Bernd HW; Hatton D; Merz H; Feller AC; Lange K
Anticancer Res; 2003; 23(2B):1555-8. PubMed ID: 12820423
[TBL] [Abstract][Full Text] [Related]
7. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
van den Oord JJ; Paemen L; Opdenakker G; de Wolf-Peeters C
Am J Pathol; 1997 Sep; 151(3):665-70. PubMed ID: 9284814
[TBL] [Abstract][Full Text] [Related]
8. [KI-1-positive, anaplastic, large-cell lymphoma related to Hodgkin's disease].
Veiga M; Fresno MF; Pérez del Río MJ; García I; Madrigal B; Herrero A
Sangre (Barc); 1997 Feb; 42(1):81-4. PubMed ID: 9229809
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological correlations of TIMP-1 and TIMP-2 in Hodgkin's lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2004 Jan; 72(1):1-9. PubMed ID: 14962256
[TBL] [Abstract][Full Text] [Related]
10. [Expression of extracellular matrix metalloproteinase inducer in human bladder transitional cell carcinoma].
Han JL; Xie WL; Huang J; Yao YS
Ai Zheng; 2003 Nov; 22(11):1158-61. PubMed ID: 14613643
[TBL] [Abstract][Full Text] [Related]
11. Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma.
Rosenthal EL; Shreenivas S; Peters GE; Grizzle WE; Desmond R; Gladson CL
Laryngoscope; 2003 Aug; 113(8):1406-10. PubMed ID: 12897567
[TBL] [Abstract][Full Text] [Related]
12. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
13. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435
[TBL] [Abstract][Full Text] [Related]
14. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns?
Menestrina F; Chilosi M; Scarpa A
Semin Diagn Pathol; 1995 Aug; 12(3):256-69. PubMed ID: 8545592
[TBL] [Abstract][Full Text] [Related]
15. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
16. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
18. Expression of emmprin by oral squamous cell carcinoma.
Bordador LC; Li X; Toole B; Chen B; Regezi J; Zardi L; Hu Y; Ramos DM
Int J Cancer; 2000 Feb; 85(3):347-52. PubMed ID: 10652425
[TBL] [Abstract][Full Text] [Related]
19. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface.
Guo H; Li R; Zucker S; Toole BP
Cancer Res; 2000 Feb; 60(4):888-91. PubMed ID: 10706100
[TBL] [Abstract][Full Text] [Related]
20. Expression of extracellular matrix metalloproteinase inducer in human placenta and fetal membranes at term labor.
Li W; Alfaidy N; Challis JR
J Clin Endocrinol Metab; 2004 Jun; 89(6):2897-904. PubMed ID: 15181074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]